Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Sanofi and Schrödinger have struck a deal under which Schrödinger will provide computational drug design support to the French drugmaker. Schrödinger could receive up to $120 million under the multiyear agreement. Sanofi intends to take advantage of Schrödinger’s advances in the areas of protein and ligand structure determination and potency prediction. The partners say they will use a new informatics system to facilitate collaboration between computational designers and medicinal chemists.
This article has been sent to the following recipient: